Antifibrotic effect of interferon gamma in silicosis model of rat

被引:39
作者
Chen, Y [1 ]
Chen, J [1 ]
Dong, J [1 ]
Liu, WY [1 ]
机构
[1] China Med Univ, Div Pneumoconiosis, Sch Publ Hlth, Shenyang 110001, Peoples R China
关键词
antifibrotic effect; interferon gamma; experimental silicosis; interleukin-4; transforming growth factor-beta 1;
D O I
10.1016/j.toxlet.2004.10.011
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 [卫生毒理学];
摘要
This study presents the antifibrotic effect of interferon gamma (IFN-gamma,) in silicosis of rats. Wistar rats were received saline or 20 mg of quartz by intratracheal instillation. The next day after instillation, silicosis model of rats were daily treated IFN-gamma (1.0 x 10(5) units/rat) or saline by intramuscular route. At 1 month or 2 months after instillation, rats were sacrificed to determine hydroxyproline content and observe the change of fibrosis and expression of interleukin-4 (IL-4) and transforming growth factor-beta1 (TGF-beta1) in the lung of rats. The hydroxyproline content of IFN-gamma treated groups was significantly lower than that of quartz groups (P < 0.05). At I month after instillation, there were Stage II and II+ of silicotic nodules in quartz group; however, in IFN-gamma treated group only cellular nodules (Stage I) were observed. At 2 months after instillation, there was Stage II+ and III of silicotic nodules in quartz group. In IFN-gamma treated group Stage 11 was found. The expressions of IL-4 (2.19 +/- 0.90, 0.61 +/- 0.22, respectively) and TGF-beta1 (1.37 +/- 0.31, 1.76 +/- 0.72, respectively) in IFN-gamma treated groups were significantly lower than those in quartz groups (IL-4: 3.33 +/- 1.27, 1.99 +/- 0.80; TGF-beta1 1: 3.67 +/- 0.63, 4.90 +/- 1.11, respectively; P < 0.05 or P < 0.01). It may be concluded that the decreased expression of IL-4 and TGF-beta1 may be associated with decreased hydroxyproline synthesis, which then results in decreased lung fibrosis. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:353 / 360
页数:8
相关论文
共 12 条
[1]
Mads and Smads in TGFβ signalling [J].
Attisano, L ;
Wrana, JL .
CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (02) :188-194
[2]
STRAP and Smad7 synergize in the inhibition of transforming growth factor β signaling [J].
Datta, PK ;
Moses, HL .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (09) :3157-3167
[3]
Molecular mechanisms of TGF-β antagonism by interferon γ and cyclosporine A in lung fibroblasts [J].
Eickelberg, O ;
Pansky, A ;
Koehler, E ;
Bihl, M ;
Tamm, M ;
Hildebrand, P ;
Perruchoud, AP ;
Kashgarian, M ;
Roth, M .
FASEB JOURNAL, 2001, 15 (03) :797-806
[4]
Antagonistic regulation of type I collagen gene expression by interferon-γ and transforming growth factor-β -: Integration at the level of p300/CBP transcriptional coactivators [J].
Ghosh, AK ;
Yuan, WH ;
Mori, Y ;
Chen, SJ ;
Varga, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (14) :11041-11048
[5]
Medical progress: Idiopathic pulmonary fibrosis. [J].
Gross, TJ ;
Hunninghake, GW .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (07) :517-525
[6]
Jaffe HA, 1999, EXP LUNG RES, V25, P199
[7]
Interstitial fibrosis and growth factors [J].
Lasky, JA ;
Brody, AR .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2000, 108 :751-762
[8]
Is Smad3 a major player in signal transduction pathways leading to fibrogenesis? [J].
Roberts, AB ;
Piek, E ;
Böttinger, EP ;
Ashcroft, G ;
Mitchell, JB ;
Flanders, KC .
CHEST, 2001, 120 (01) :43S-47S
[9]
Fibrosis of the lung and other tissues: New concepts in pathogenesis and treatment [J].
Sime, PJ ;
O'Reilly, KMA .
CLINICAL IMMUNOLOGY, 2001, 99 (03) :308-319
[10]
Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway [J].
Ulloa, L ;
Doody, J ;
Massagué, J .
NATURE, 1999, 397 (6721) :710-713